| Key Financial Ratios of Sun Pharmaceutical Industries (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
17.80 |
11.90 |
7.00 |
-0.40 |
8.92 |
|
| Diluted EPS (Rs.) |
17.80 |
11.90 |
7.00 |
-0.40 |
8.92 |
|
| Cash EPS (Rs.) |
23.01 |
18.58 |
13.72 |
5.21 |
11.36 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
101.45 |
98.76 |
98.98 |
102.48 |
104.36 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
101.45 |
98.76 |
98.98 |
102.48 |
104.36 |
|
| Dividend / Share(Rs.) |
16.00 |
13.50 |
11.50 |
10.00 |
7.50 |
|
| Revenue from Operations/Share (Rs.) |
95.88 |
84.50 |
86.74 |
64.96 |
53.36 |
|
| PBDIT/Share (Rs.) |
29.85 |
25.23 |
28.14 |
16.11 |
12.86 |
|
| PBIT/Share (Rs.) |
24.69 |
18.56 |
21.47 |
10.48 |
10.42 |
|
| PBT/Share (Rs.) |
20.97 |
14.38 |
7.26 |
1.28 |
8.97 |
|
| Net Profit/Share (Rs.) |
17.85 |
11.91 |
7.05 |
-0.42 |
8.92 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
31.13 |
29.85 |
32.44 |
24.80 |
24.10 |
|
| PBIT Margin (%) |
25.75 |
21.96 |
24.75 |
16.13 |
19.52 |
|
| PBT Margin (%) |
21.86 |
17.01 |
8.36 |
1.96 |
16.81 |
|
| Net Profit Margin (%) |
18.61 |
14.09 |
8.12 |
-0.64 |
16.71 |
|
| Return on Networth / Equity (%) |
17.59 |
12.06 |
7.11 |
-0.40 |
8.54 |
|
| Return on Capital Employed (%) |
23.57 |
12.15 |
15.79 |
8.20 |
8.15 |
|
| Return on Assets (%) |
9.89 |
6.96 |
4.12 |
-0.24 |
5.48 |
|
| Total Debt/Equity (X) |
0.45 |
0.47 |
0.32 |
0.20 |
0.26 |
|
| Asset Turnover Ratio (%) |
0.55 |
0.49 |
0.51 |
0.39 |
0.33 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
1.03 |
3.36 |
1.97 |
0.96 |
1.45 |
|
| Quick Ratio (X) |
0.82 |
2.59 |
1.49 |
0.62 |
1.07 |
|
| Inventory Turnover Ratio (X) |
6.28 |
1.20 |
1.40 |
1.40 |
1.31 |
|
| Dividend Payout Ratio (NP) (%) |
84.38 |
101.39 |
149.00 |
-2,159.12 |
72.86 |
|
| Dividend Payout Ratio (CP) (%) |
65.45 |
64.99 |
76.53 |
172.71 |
57.18 |
|
| Earnings Retention Ratio (%) |
15.62 |
-1.39 |
-49.00 |
2,259.12 |
27.14 |
|
| Cash Earnings Retention Ratio (%) |
34.55 |
35.01 |
23.47 |
-72.71 |
42.82 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
426,430.49 |
399,514.79 |
243,046.57 |
223,821.71 |
149,635.45 |
|
| EV/Net Operating Revenue (X) |
18.54 |
19.70 |
11.68 |
14.36 |
11.69 |
|
| EV/EBITDA (X) |
59.54 |
66.00 |
36.00 |
57.90 |
48.49 |
|
| MarketCap/Net Operating Revenue (X) |
18.10 |
19.18 |
11.33 |
14.08 |
11.20 |
|
| Retention Ratios (%) |
15.61 |
-1.39 |
-49.00 |
2,259.12 |
27.13 |
|
| Price/BV (X) |
17.11 |
16.41 |
9.93 |
8.93 |
5.73 |
|
| Price/Net Operating Revenue |
18.10 |
19.18 |
11.33 |
14.08 |
11.20 |
|
| Earnings Yield |
0.01 |
0.01 |
0.01 |
0.00 |
0.01 |
|
Source : Dion Global Solutions Limited
